Rezultati pretraživanja
  1. prije 15 minuta

    Very high bifurcation (image in reply).

    Prikaži ovu nit
  2. Are you concerned about patient prosthesis mismatch (PPM)? Read how PPM matters in and review the data here.

  3. TAVR study results recently published in the New England Journal of Medicine. The study compared transcatheter vs. surgical aortic valve replacements in 2032 patients. 

  4. 5-yr post-op outcomes similar among heart patients who undergo either or , analysis indicates. :

  5. Congratulations to for graduating! It takes a village to make a and ...both at work and at home. Excited for him as he starts his fellowship in and .

    Prikaži ovu nit
  6. Stroke happens, protection works. In its IDE trial, SENTINEL™ captured embolic debris in 99% of patients. Safety info:

  7. prije 6 sati

    It would be nice if TVT registry would allow a similar analysis between SAPIEN and Evolut and to see if US experience is similar to this French one. any luck in convincing TVT folks to allow such a study?

  8. prije 8 sati

    JACC editorial on non-nominal deployment on Word of caution on oversizing. Bench testing has demonstrated that extreme overexpansion has risks of leaflet damage and impaired leaflet coaptation that can compromise long-term THV performance .

  9. prije 8 sati

    One from Germany last week 🇩🇪 A great week spent with the team at the meeting. It’s very exciting times for

  10. prije 9 sati
  11. prije 21 sat
    Odgovor korisnicima i sljedećem broju korisnika:

    That’s why we need improvement on the next generation valves, achieving these great results on PVL, but without missing area and gradient because the results are below what we need on bicuspids

  12. 2. velj

    Very challenging , 61 years M with bicuspid AS Sievers type zero, morbid BMI=60 😲, DM, LAD stent, recent stroke, turned down by surgery b/c of extreme risk. done with Trans-femoral 27 mm Edge, & closure device. No BAV done. Discharged 🏠 next day.

    Prikaži ovu nit
  13. 1. velj

    This article provides an in-depth review of current evidence concerning adjunctive antithrombotic therapy in patients with AS undergoing

  14. 1. velj

    First subclavian . Mitroflow 23,VTSTJ<2mm. Transversal by l. femoral. No r. femoral access. Subclavia for snare/Esheath.Forgot replacing Backup Meier for pigtail. Pull force standard. Just luck or anybody had difficulties lacerating with wire in place?

  15. 31. sij

    LV pacing TAVR. . Valve in valve. Patient has already a permanent pacer. LV pacing can be done as a routine in those scenarios.

  16. 31. sij

    83 y/o male, symptomatic Aortic stenosis ➡️ ➡️ Edwards Sapien 3 ➡️ good hemodynamics ➡️ sinus rhythm ➡️ No PVL ✅

  17. Odgovor korisnicima i sljedećem broju korisnika:

    Didn’t read it yet but 1 concepts have evolved in last 5 yrs significantly (implant height & generous sizing w lower PVL & PPM) 2 Wonder if results confounded by transthoracic which were 1/4 of cases (generally better results w transfemoral)

  18. 30. sij

    5 year partner 2 FU. TAVR ⬆️ PVL and ⬆️ reintervention and mortality curves cross although NS yet. Warning for expanding TAVR to low risk 🛑 need more data.

  19. 30. sij

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.